These FTSE 100 stocks have surged 20% in the last 3 months. Time to cash in?

Royston Wild considers the share price prospects of two FTSE 100 (INDEXFTSE: UKX) fizzers.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Despite fears that the UK economy could be in for heavy weather from 2017, investor appetite for Royal Bank of Scotland Group (LSE: RBS) has marched steadily higher during the past few months.

The financial giant has seen its share value stomp 18% higher since the end of October. But I believe savvy shareholders should consider cashing in on these gains.

Sure, economic data since June’s EU referendum may not have been as disastrous as many economists had predicted, sweeping RBS away from the summer’s eight-and-a-half-year troughs. But economic data more recently suggests that the banking sector may be in for a tough time in the months ahead, like rising inflation and a weakening jobs market. RBS already faces a worrying revenues outlook following the aggressive asset-shedding of recent years.

However, a sliding UK economy is not the only problem as it faces up to a probable leap in misconduct-related costs. The Financial Ombudsman has witnessed a fresh surge in PPI claims recently as a possible FCA deadline looms into view. And last week RBS was forced to stash away an extra £3.1bn to cover costs related to the mis-selling of financial products in the US prior to the 2008 crash.

And in my opinion RBS’s valuations certainly don’t leave room for further share price strength. A predicted 19% earnings rise in 2017 — a figure I believe could be downgraded sooner rather than later — results in a P/E ratio of 14 times, above the benchmark of 10 times indicative of high-risk stocks.

And a 0.2% dividend yield lags the FTSE 100 forward average of 3.5% by a considerable distance. Besides, RBS’s failure to hurdle Bank of England stress tests late last year leaves questions around whether the bank will be able to meet even this modest payout projection.

I fully expect the share price to trek lower again as we move through 2017.

Bed down

Accommodation play InterContinental Hotels Group (LSE: IHG) has also seen its share price shoot higher in recent months, the stock gaining 21% in value since the latter days of October and powering to record highs just on Friday.

And I believe investors have a lot to get excited about looking ahead. InterContinental Hotels saw US revenues per available room (or REVPAR) tick 1.4% higher during July-September. And occupancy rates rose above 75% thanks to “continued record levels of industry demand.” Strong economic growth Stateside should continue to fuel demand for its beds.

But North America isn’t the only story, certainly in the long term, and I expect the company’s expansion drive across both developed and emerging economies to create exceptional revenues growth.

So despite InterContinental Hotels dealing on a slightly-expensive forward P/E ratio of 21 times, I reckon City projections of sustained double-digit earnings growth from this year warrant serious attention, even at current prices.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing For Beginners

The Barclays share price keeps surging! Was I wrong to sell the stock?

Jon Smith explains why the Barclays share price is still rising, even though he feels that further gains could be…

Read more »

Investing Articles

1 stock set to gatecrash the FTSE 100 in 2025!

Our writer considers a quality stock that's poised to join the FTSE 100 next year. Could there also be a…

Read more »

Businesswoman calculating finances in an office
Investing Articles

As earnings growth boosts the Imperial Brands share price, is it a top FTSE 100 dividend choice?

The Imperial Brands share price has come storming back as investors piled in for the big dividends. What's next, after…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
US Stock

Warren Buffett just bought and sold these stocks. Here’s why I don’t agree

Jon Smith takes a look at the recent regulatory filing for Berkshire Hathaway and Warren Buffett and comments on recent…

Read more »

US Stock

My favourite US growth stock’s up 33% this year. I think it’s just getting started

Edward Sheldon's taken a large position in this well-known S&P 500 growth stock. And so far, it’s working very well…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

The Diploma share price falls 7% as revenues and profits keep growing. Time to buy?

As Diploma continues its impressive growth, its share price is faltering. Stephen Wright takes a closer look at one of…

Read more »

Growth Shares

Directors at this FTSE 100 company just bought over £2m worth of shares

Shares in this FTSE 100 pharma company have plummeted in recent months. And company insiders are betting on a potential…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Down 24%! As the Glencore share price falls like snow, is it finally time to let it go?

Harvey Jones thought the Glencore share price was in bargain territory when he bought the FTSE 100 commodity giant last…

Read more »